Bullfrog AI (BFRG) Registration filing summary
Event summary combining transcript, slides, and related documents.
Registration filing summary
5 Oct, 2026Offering details and pricing
S-3 registration provides for delayed or continuous sales under Rule 415, beginning from time to time after the registration statement becomes effective.
Exhibit index lists forms for an underwriting agreement, preferred stock, warrants, stock purchase agreements and unit agreements.
Management team and governance
Vininder Singh signed as CEO and director; Dane Saglio signed as CFO and principal financial and accounting officer.
R. Donald Elsey, William Enright and Jason D. Hanson are listed as directors.
Key takeaways
The Aug. 15, 2024 amendment revises Item 16 and files a modified auditor consent; it does not change the preliminary prospectus or other registration provisions.
M&K CPAs consented to inclusion of audit reports covering consolidated financial statements for FY2023 and FY2022, and FY2022 and FY2021.
Latest events from Bullfrog AI
- AI platform targets drug discovery economics, backed by a pharma deal and expanding pipeline.BFRG
LD Micro 20th Annual Main Event Conference - A warrant-resale registration amid early-stage drug development and ongoing funding needs.BFRG
Registration filing - Resale registration could yield up to $3.26M, contingent on cash warrant exercises.BFRG
Registration filing - Four proposals seek a $10M equity facility, reverse-split authority and expanded equity awards.BFRG
Proxy filing - A $100 million shelf backs an early-stage AI drug strategy facing financing and clinical risks.BFRG
Registration filing - Four directors face election as shareholders consider auditor ratification for FY2025.BFRG
Proxy filing - Four director nominees and M & K auditor ratification anchor the 2024 virtual meeting agenda.BFRG
Proxy filing - Votes cover financing dilution, a discretionary reverse split and a 750,000-share Plan increase.BFRG
Proxy filing - A conditional $10 million equity facility brings potential liquidity and substantial dilution risk.BFRG
Registration filing